Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease

Omeprazole-Domperidone Fixed Dose Combination vs Omeprazole Monotherapy: A Phase 4, Open-Label, Comparative, Parallel Randomized Controlled Study in Mild to Moderate Gastroesophageal Reflux Disease

Aim: To compare the efficacy and safety of omeprazole-domperidone combination vs omeprazole monotherapy in gastroesophageal reflux disease (GERD). Methods: In a comparative, randomized controlled, phase 4 study, outpatients with GERD were randomly allocated to either group 1 (omeprazole 20 mg + domp...

Full description

Bibliographic Details
Main Authors: KY Marakhouski, GA Karaseva, DN Ulasivich, Y Kh Marakhouski
Format: Article
Language:English
Published: SAGE Publishing 2017-05-01
Series:Clinical Medicine Insights: Gastroenterology
Online Access:https://dx.doi.org/10.1177/1179552217709456

Similar Items

Similar Items